Mechanical mitral valve replacement: a multicenter study of outcomes with use of 15-to 17-mm prostheses

Autor: Felix Haas, Ryan E. Accord, Mark G. Hazekamp, Gerald R. Marx, Wouter J. van Leeuwen, Herbert van Wetten, Angelika Muter, Rinske IJsselhof, Martijn G. Slieker, Paul H. Schoof, Meena Nathan, Kimberlee Gauvreau
Přispěvatelé: Cardiothoracic Surgery
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
Reoperation
Pulmonary and Respiratory Medicine
medicine.medical_specialty
medicine.medical_treatment
Heart Valve Diseases
INFANTS
CHILDREN
030204 cardiovascular system & hematology
Prosthesis Design
Prosthesis
RECOMMENDATIONS
03 medical and health sciences
0302 clinical medicine
Aortic valve repair
All institutes and research themes of the Radboud University Medical Center
Mechanical Mitral Valve
Aortic valve replacement
Mitral valve
MELODY
medicine
Humans
Adverse effect
PREDICTORS
Netherlands
Retrospective Studies
Heart Valve Prosthesis Implantation
RISK
business.industry
Other Research Radboud Institute for Health Sciences [Radboudumc 0]
Mitral valve replacement
Infant
Retrospective cohort study
medicine.disease
United States
EVOLUTION
Surgery
Survival Rate
Treatment Outcome
medicine.anatomical_structure
030228 respiratory system
Heart Valve Prosthesis
Mitral Valve
Female
Cardiology and Cardiovascular Medicine
business
Zdroj: The Annals of Thoracic Surgery, 110(6), 2062-2069. ELSEVIER SCIENCE INC
Annals of Thoracic Surgery, 110, 6, pp. 2062-2069
Annals of Thoracic Surgery, 110(6), 2062-2069. Elsevier Inc.
Annals of thoracic surgery, 110(6), 2062-2069. ELSEVIER SCIENCE INC
Annals of Thoracic Surgery, 110, 2062-2069
ISSN: 0003-4975
Popis: Background. The aim of this study was to evaluate early and mid-term outcomes (mortality and prosthetic valve reintervention) after mitral valve replacement with 15- to 17-mm mechanical prostheses.Methods. A multicenter, retrospective cohort study was performed among patients who underwent mitral valve replacement with a 15- to 17-mm mechanical prosthesis at 6 congenital cardiac centers: 5 in The Netherlands and 1 in the United States. Baseline, operative, and follow-up data were evaluated.Results. Mitral valve replacement was performed in 61 infants (15 mm, n = 17 [28%]; 16 mm, n = 18 [29%]; 17 mm, n = 26 [43%]), of whom 27 (47%) were admitted to the intensive care unit before surgery and 22 (39%) required ventilator support. Median age at surgery was 5.9 months (interquartile range [IQR] 3.2-17.4), and median weight was 5.7 kg (IQR, 4.5-8.8). There were 13 in-hospital deaths (21%) and 8 late deaths (17%, among 48 hospital survivors). Major adverse events occurred in 34 (56%). Median follow-up was 4.0 years (IQR, 0.4-12.5) First prosthetic valve replacement (n = 27 [44%]) occurred at a median of 3.7 years (IQR, 1.9-6.8). Prosthetic valve endocarditis was not reported, and there was no mortality related to prosthesis replacement. Other reinterventions included permanent pacemaker implantation (n = 9 [15%]), subaortic stenosis resection (n = 4 [7%]), aortic valve repair (n = 3 [5%], and aortic valve replacement (n = 6 [10%]).Conclusions. Mitral valve replacement with 15- to 17-mm mechanical prostheses is an important alternative to save critically ill neonates and infants in whom the mitral valve cannot be repaired. Prosthesis replacement for outgrowth can be carried out with low risk. (C) 2020 by The Society of Thoracic Surgeons. Published by Elsevier Inc.
Databáze: OpenAIRE